Oncology Pharmacists: Drug Costs & Workforce Challenges
- This article details a panel discussion focusing on the challenges and opportunities facing oncology pharmacy.Here's a breakdown of the key points:
- * High Costs: New cancer therapies can be incredibly expensive, ranging up to $500,000 per treatment.
- * Pharmacist Role in Offloading: Pharmacists are crucial for relieving workload from oncologists, especially given the physician shortage.
Key Takeaways from the Oncology Pharmacy Panel Discussion:
This article details a panel discussion focusing on the challenges and opportunities facing oncology pharmacy.Here’s a breakdown of the key points:
1. Rising Drug Costs & Cost Management:
* High Costs: New cancer therapies can be incredibly expensive, ranging up to $500,000 per treatment.
* Shifting Care: Moving treatment from inpatient to outpatient settings is a key strategy to reduce costs.
* Holistic resource Assessment: practices need to consider all resources required to deliver a drug, including potential hospital collaborations, when evaluating cost.
* ROI difficulty: Demonstrating the return on investment for pharmacy services is challenging.
2. Addressing the provider Shortage (Physicians & Pharmacists):
* Pharmacist Role in Offloading: Pharmacists are crucial for relieving workload from oncologists, especially given the physician shortage.
* Oncology Pharmacist Shortage: A shortage of specialized oncology pharmacists is emerging.
* Remote Work & Retention: Leveraging remote work for administrative tasks and reducing travel for professional development are strategies to retain pharmacists.
* Training & Hiring: Institutions are increasingly hiring recent graduates or retail pharmacists and providing specialized oncology training.
3. The Value of Oncology Pharmacists:
* Increased Efficiency: Integrating pharmacists into teams improves clinic efficiency, allowing more patients to be seen.
* Patient Education: Pharmacists ensure patients understand how to take their medications, particularly complex IV-to-oral regimens, at home.
* Adverse Event Management: Pharmacists are experts in drug profiles and identifying patients at risk for adverse events. They participate in tumor boards to assess patient suitability for therapies and recommend preventative measures.
* Patient Support: Pharmacists are often the first point of contact for patients with questions about their treatment or side effects, providing crucial outpatient education.
* Coordination of Care: They coordinate the use of [the article ends abruptly here, implying further discussion of care coordination].
In essence, the panel highlights the growing importance of oncology pharmacists in navigating the complexities of cancer treatment – from managing costs and addressing workforce shortages to optimizing patient care and safety.
- Victoria Public Hospital Doctors Vote to Strike Over Working Conditions
- Lessons in Community-Based HIV and AIDS Care From Jamaica EVE For Life
- Rising Crime Victim Legal Costs as Prosecutor Direct Investigation Declines (archynewsy.com)
- RAP vs. IBR: What Your New Student Loan Bill Actually Costs (daybreakwire.com)
